HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE

Provided is an agent which is a novel drug for the treatment or prevention of diabetes in that the agent possesses serine protease-inhibiting activity and thereby inhibits an increase in the blood glucose level. The agent is a compound represented by general formula (I) or a pharmaceutically accepta...

Full description

Saved in:
Bibliographic Details
Main Authors TOKUMASU, MUNETAKA, IKEHARA, OSAMU, KONISHI, ATSUSHI, OHSUMI, KOJI, KODAMA, YUKO, SUZUKI, TAMOTSU, KOSHIBA, TAKAHIRO
Format Patent
LanguageEnglish
French
Published 16.06.2011
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided is an agent which is a novel drug for the treatment or prevention of diabetes in that the agent possesses serine protease-inhibiting activity and thereby inhibits an increase in the blood glucose level. The agent is a compound represented by general formula (I) or a pharmaceutically acceptable salt thereof. (I) La présente invention concerne un agent qui est un nouveau médicament convenant au traitement ou à la prévention du diabète, dans lequel l'agent présente une activité inhibitrice des protéases de la sérine, et qui bloque ainsi l'augmentation de la glycémie. Cet agent est un composé représenté par la formule générale (I) ou l'un de ses sels pharmaceutiquement admis.
Bibliography:Application Number: WO2010JP71929